CHMG
Chemung Financial Corporation
CHMG has the edge over HOOD overall, supported by stronger fundamentals and lower modeled downside.
HOOD
Robinhood Markets, Inc.
HOOD offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CHMG Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
CHMG's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like CHMG.
HOOD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
HOOD's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like HOOD.
CHMG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.7x | $61.52 | -28% |
| Fair | 9x | $71.85 | -16% |
| Forward | 10x | $85.69 | — |
| Current | 11x | $85.69 | — |
| Expensive | 12x | $96.93 | +13% |
Historical ranges are pointers, not guarantees.
CHMG's PE is in its expensive range at 11x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
HOOD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 30x | $81.35 | — |
| Cheap | 37x | $78.84 | -3.1% |
| Current | 38x | $81.35 | — |
| Fair | 51x | $110 | +35% |
| Expensive | 74x | $160 | +96% |
Historical ranges are pointers, not guarantees.
HOOD has the edge over CHMG in the historical PE scenario, which offers more potential upside but is not a forecast.
CHMG Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CHMG, with profitability improving.
HOOD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
HOOD has the edge over CHMG on the outlook, with more favorable valuation expectations.
CHMG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.38 | +5.2% |
| Q3 2026 | $7.97 | +188% |
| Q2 2026 | $6.96 | +197% |
| Q1 2026 | $3.79 | -20% |
| Q4 2025 | $3.14 | -37% |
| Q3 2025 | $2.77 | -39% |
| Q2 2025 | $2.34 | -53% |
| Q1 2025 | $4.74 | -9.2% |
| Q4 2024 | $4.96 | -6.1% |
CHMG earned $7.97 per share over the past year, up 188% from the year before.
HOOD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.72 | +26% |
| Q3 2026 | $2.16 | -10% |
| Q2 2026 | $2.26 | +15% |
| Q1 2026 | $2.06 | +18% |
| Q4 2025 | $2.05 | +31% |
| Q3 2025 | $2.40 | +314% |
| Q2 2025 | $1.96 | +513% |
| Q1 2025 | $1.75 | +1150% |
| Q4 2024 | $1.56 | +$2.17 |
HOOD has the edge over CHMG on earnings, with more consistent year-over-year improvement.
CHMG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32M | +11% |
| Q2 2026 | $31.2M | +209% |
| Q1 2026 | $29.9M | +16% |
| Q4 2025 | $30.5M | +18% |
| Q3 2025 | $28.8M | +18% |
| Q2 2025 | $10.1M | -57% |
| Q1 2025 | $25.7M | +8.3% |
| Q4 2024 | $25.9M | +8.9% |
CHMG's revenue has grown year over year for five quarters in a row: $32M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 52% | +17 points |
| Q2 2026 | 36% | +123 points |
| Q1 2026 | 40% | +9.7 points |
| Q4 2025 | 36% | +7 points |
| Q3 2025 | 35% | +5.2 points |
| Q2 2025 | -87% | -114 points |
| Q1 2025 | 30% | -8.4 points |
| Q4 2024 | 29% | +9.5 points |
CHMG has the edge over HOOD on profitability, with a higher operating margin.
HOOD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +12% |
| Q2 2026 | $1.3B | +32% |
| Q1 2026 | $1.1B | +15% |
| Q4 2025 | $1.3B | +27% |
| Q3 2025 | $1.3B | +100% |
| Q2 2025 | $989M | +45% |
| Q1 2025 | $927M | +50% |
| Q4 2024 | $1B | +115% |
HOOD has the edge over CHMG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 44% | -5.9 points |
| Q2 2026 | 54% | +9.5 points |
| Q1 2026 | 39% | -1.5 points |
| Q4 2025 | 52% | -3.5 points |
| Q3 2025 | 50% | +26 points |
| Q2 2025 | 45% | +17 points |
| Q1 2025 | 40% | +14 points |
| Q4 2024 | 55% | +49 points |
HOOD's operating margin was 44% last quarter, down 5.9 points from the same quarter a year ago.
CHMG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $10.7M | -9.2% |
| Q2 2026 | $8.9M | -5.1% |
| Q1 2026 | $8.9M | +30% |
| Q4 2025 | $15.7M | +265% |
| Q3 2025 | $11.8M | +38% |
| Q2 2025 | $9.4M | +72% |
| Q1 2025 | $6.9M | -13% |
| Q4 2024 | $4.3M | +19% |
CHMG's free cash flow was $44M over the past year, up 37% from the year before. Free cash flow isn't a meaningful measure for financial services companies like CHMG.
HOOD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +$2.8B |
| Q2 2026 | $720M | -79% |
| Q1 2026 | $2B | +217% |
| Q4 2025 | -$937M | +$463M |
| Q3 2025 | -$1.6B | -187% |
| Q2 2025 | $3.5B | +6398% |
| Q1 2025 | $642M | +$1.3B |
| Q4 2024 | -$1.4B | -246% |
HOOD's free cash flow was $3B over the past year, up 159% from the year before. Free cash flow isn't a meaningful measure for financial services companies like HOOD.
CHMG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1.3K shares |
| 1 year | +0.6% | +28.3K shares |
| 3 years | +2.2% | +103K shares |
| 5 years | +3.3% | +155K shares |
| Available history | -0.6% | -30K shares |
CHMG has 5M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $58,000 |
| Q2 2026 | $11,000 |
| Q1 2026 | $173,000 |
| Q4 2025 | $295,000 |
| Q3 2025 | $11,000 |
| Q2 2025 | $5,000 |
| Q1 2025 | $85,000 |
| Q4 2024 | $252,000 |
CHMG spent $537,000 buying back its own shares over the past year, up 52% from the year before.
HOOD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -1M shares |
| 1 year | -0.8% | -6.9M shares |
| 3 years | +1.8% | +15.9M shares |
| 5 years | +292% | +679M shares |
| Available history | +7.2% | +60.8M shares |
HOOD has the edge over CHMG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25M |
| Q2 2026 | $414M |
| Q1 2026 | $250M |
| Q4 2025 | $100M |
| Q3 2025 | $107M |
| Q2 2025 | $124M |
| Q1 2025 | $322M |
| Q4 2024 | $160M |
HOOD spent $789M buying back its own shares over the past year, up 11% from the year before.
CHMG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.6x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -14.3x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.5x | Net Cash |
CHMG has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CHMG.
HOOD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -3.3x | Net Cash |
| Q4 2024 | -3.8x | Net Cash |
HOOD has the edge over CHMG on leverage, with a lower net debt burden relative to earnings.
CHMG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.6 | Neutral |
| Stochastic | 70.2 | Neutral |
CHMG's weekly RSI is 68 (neutral) and its Stochastic is 70 (neutral).
HOOD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.8 | Neutral |
| Stochastic | 9.5 | Oversold |
HOOD's weekly RSI is 41 (neutral) and its Stochastic is 10 (oversold).
CHMG PE vs Financial Services Sector
| Metric | CHMG | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 17% below |
| PE % | 74 | 63 | 11 pts above |
CHMG has the edge over HOOD on valuation relative to its sector.
HOOD PE vs Financial Services Sector
| Metric | HOOD | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 13x | 189% above |
| PE % | 22 | 66 | 44 pts below |
HOOD is trading at 38x earnings, a 189% premium to the Financial Services sector's median of 13x.
CHMG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $83.2 | 3% above |
| 20 week MA | $81.8 | 4.8% above |
| 50 week MA | $69.3 | 24% above |
| 100 week MA | $59.3 | 45% above |
| 200 week MA | $51.9 | 65% above |
CHMG has the edge over HOOD on trend strength, trading above more of its moving averages.
HOOD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $97.8 | 17% below |
| 20 week MA | $102.2 | 20% below |
| 50 week MA | $95.4 | 15% below |
| 100 week MA | $88.5 | 8.1% below |
| 200 week MA | $52.1 | 56% above |
HOOD has fallen below most of its moving averages, though it's still 56% above its 200-week average.
CHMG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.5 | $33.7 | -21% |
| 2021 | $33.7 | $46.5 | +38% |
| 2022 | $46.5 | $44.9 | -3.4% |
| 2023 | $44.9 | $49.8 | +11% |
| 2024 | $49.8 | $49.4 | -0.8% |
| 2025 | $49.4 | $55.3 | +12% |
| 2026 YTD | $55.3 | $85.7 | +55% |
CHMG has the edge over HOOD on returns for 2026, with the stronger performance.
HOOD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $35.2 | $18.9 | -46% |
| 2022 | $18.9 | $7.95 | -58% |
| 2023 | $7.95 | $12.7 | +60% |
| 2024 | $12.7 | $39.0 | +206% |
| 2025 | $39.0 | $118.1 | +203% |
| 2026 YTD | $118.1 | $81.4 | -31% |
HOOD's yearly returns have swung widely, from +206% in 2024 to −58% in 2022. It's down 31% so far in 2026.